Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.1400 (31.11%)
May 26, 2026, 9:30 AM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $4.41 million as of May 27, 2026. Its market cap has decreased by -69.35% in one year.
Market Cap
4.41M
Enterprise Value
22.56M
Revenue
1.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.59
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 4.41M, an increase of 1,643.48%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 4.41M | 348.68% |
| Dec 31, 2025 | 982.83K | -89.94% |
| Dec 31, 2024 | 9.77M | -38.79% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Institute of Biomedical Research | 6.05M |
| Mosaic ImmunoEngineering | 5.33M |
| Reviva Pharmaceuticals Holdings | 5.24M |
| GPL Holdings | 4.17M |
| AccuStem Sciences | 4.14M |
| Iterum Therapeutics | 3.96M |
| Bioxytran | 3.43M |
| Enzolytics | 3.38M |